trial

Using mHealth to Optimize Pharmacotherapy Regimens

NCTId NCT04248517
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 23 (actual)
Sponsored by New York State Psychiatric Institute, Washington Heights Community Service
Primary completion 2022-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
23 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2020-10-09
Primary completion
2022-12-31
Eligibility
ALL · 16 Years · 30 Years

Interventions & indications

Drugs
mHealth Intervention

Sponsors

New York State Psychiatric Institute, Washington Heights Community ServiceLead Sponsor
Northwell Health, Early Treatment Program at Lenox HillCollaborator
The Institute for Family Health Center for Counseling at WaltonCollaborator
New York State Psychiatric Institute, Washington Heights Community ServiceCollaborator
BestSelf Behavioral HealthCollaborator
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Scott Stroup, MD, MPHPrincipal Investigator

Sites

4 total
Buffalo, United StatesNew York, United StatesNew York, United StatesNew York, United States

Facts & assertions

4 sourced
Enrollment
23
Phase
NA
Primary Completion Date
2022-12-31
Status
COMPLETED
relationships
The graph out of here
drug
mHealth Intervention
drug
lead_sponsor
New York State Psychiatric Institute, Washington Heights Community Service
company
collaborator
Northwell Health, Early Treatment Program at Lenox Hill
company
The Institute for Family Health Center for Counseling at Walton
company
indication
Schizophrenia
indication
First-Episode Psychosis
indication
Schizophrenia
indication
investigator
Scott Stroup, MD, MPH
person